Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1999 Feb 1;337(Pt 3):537–541.

Dermatopontin interacts with transforming growth factor beta and enhances its biological activity.

O Okamoto 1, S Fujiwara 1, M Abe 1, Y Sato 1
PMCID: PMC1220007  PMID: 9895299

Abstract

Dermatopontin, a recently found low-molecular-mass component of the extracellular matrix, was studied for its interaction with decorin and transforming growth factor beta (TGF-beta) and its influence on TGF-beta bioactivity. Dermatopontin reacted with decorin with an apparent Kd of 100 nM in a solid-phase assay. Dermatopontin inhibited the formation of the decorin-TGF-beta1 complex. Decorin also competed with dermatopontin for the binding of this cytokine. The dermatopontin-decorin complex bound 3-fold more TGF-beta1 than did each component individually, and binding was inhibited more strongly by decorin preincubated with dermatopontin than by dermatopontin or decorin alone. Dermatopontin augmented the biological activity of TGF-beta1, as analysed by the expression of luciferase in mink lung epithelial cells transfected with a plasminogen activator inhibitor-promoter-luciferase construct, although dermatopontin itself did not show apparent induction of luciferase. Dermatopontin showed weak inhibitory activity on the proliferation of mink lung epithelial cells, and it enhanced the growth-inhibitory activity of TGF-beta on these cells. Thus dermatopontin increases the cellular response to TGF-beta. These findings strongly suggest that dermatopontin modifies the behaviour of TGF-beta through interaction with decorin in the microenvironment of the extracellular matrix in vivo.

Full Text

The Full Text of this article is available as a PDF (124.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abe M., Harpel J. G., Metz C. N., Nunes I., Loskutoff D. J., Rifkin D. B. An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal Biochem. 1994 Feb 1;216(2):276–284. doi: 10.1006/abio.1994.1042. [DOI] [PubMed] [Google Scholar]
  2. Abe M., Oda N., Sato Y. Cell-associated activation of latent transforming growth factor-beta by calpain. J Cell Physiol. 1998 Feb;174(2):186–193. doi: 10.1002/(SICI)1097-4652(199802)174:2<186::AID-JCP6>3.0.CO;2-K. [DOI] [PubMed] [Google Scholar]
  3. Alevizopoulos A., Mermod N. Transforming growth factor-beta: the breaking open of a black box. Bioessays. 1997 Jul;19(7):581–591. doi: 10.1002/bies.950190709. [DOI] [PubMed] [Google Scholar]
  4. Bidanset D. J., Guidry C., Rosenberg L. C., Choi H. U., Timpl R., Hook M. Binding of the proteoglycan decorin to collagen type VI. J Biol Chem. 1992 Mar 15;267(8):5250–5256. [PubMed] [Google Scholar]
  5. Brown D. C., Vogel K. G. Characteristics of the in vitro interaction of a small proteoglycan (PG II) of bovine tendon with type I collagen. Matrix. 1989;9(6):468–478. doi: 10.1016/s0934-8832(11)80016-8. [DOI] [PubMed] [Google Scholar]
  6. Danielson K. G., Baribault H., Holmes D. F., Graham H., Kadler K. E., Iozzo R. V. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol. 1997 Feb 10;136(3):729–743. doi: 10.1083/jcb.136.3.729. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Font B., Aubert-Foucher E., Goldschmidt D., Eichenberger D., van der Rest M. Binding of collagen XIV with the dermatan sulfate side chain of decorin. J Biol Chem. 1993 Nov 25;268(33):25015–25018. [PubMed] [Google Scholar]
  8. Forbes E. G., Cronshaw A. D., MacBeath J. R., Hulmes D. J. Tyrosine-rich acidic matrix protein (TRAMP) is a tyrosine-sulphated and widely distributed protein of the extracellular matrix. FEBS Lett. 1994 Sep 12;351(3):433–436. doi: 10.1016/0014-5793(94)00907-4. [DOI] [PubMed] [Google Scholar]
  9. Hedbom E., Heinegård D. Interaction of a 59-kDa connective tissue matrix protein with collagen I and collagen II. J Biol Chem. 1989 Apr 25;264(12):6898–6905. [PubMed] [Google Scholar]
  10. Heldin C. H., Miyazono K., ten Dijke P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature. 1997 Dec 4;390(6659):465–471. doi: 10.1038/37284. [DOI] [PubMed] [Google Scholar]
  11. Isaka Y., Brees D. K., Ikegaya K., Kaneda Y., Imai E., Noble N. A., Border W. A. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat Med. 1996 Apr;2(4):418–423. doi: 10.1038/nm0496-418. [DOI] [PubMed] [Google Scholar]
  12. Kresse H., Liszio C., Schönherr E., Fisher L. W. Critical role of glutamate in a central leucine-rich repeat of decorin for interaction with type I collagen. J Biol Chem. 1997 Jul 18;272(29):18404–18410. doi: 10.1074/jbc.272.29.18404. [DOI] [PubMed] [Google Scholar]
  13. Krumdieck R., Hök M., Rosenberg L. C., Volanakis J. E. The proteoglycan decorin binds C1q and inhibits the activity of the C1 complex. J Immunol. 1992 Dec 1;149(11):3695–3701. [PubMed] [Google Scholar]
  14. Lewandowska K., Choi H. U., Rosenberg L. C., Sasse J., Neame P. J., Culp L. A. Extracellular matrix adhesion-promoting activities of a dermatan sulfate proteoglycan-associated protein (22K) from bovine fetal skin. J Cell Sci. 1991 Jul;99(Pt 3):657–668. doi: 10.1242/jcs.99.3.657. [DOI] [PubMed] [Google Scholar]
  15. MacBeath J. R., Shackleton D. R., Hulmes D. J. Tyrosine-rich acidic matrix protein (TRAMP) accelerates collagen fibril formation in vitro. J Biol Chem. 1993 Sep 15;268(26):19826–19832. [PubMed] [Google Scholar]
  16. Nakamura T., Matsunaga E., Shinkai H. Isolation and some structural analyses of a proteodermatan sulphate from calf skin. Biochem J. 1983 Aug 1;213(2):289–296. doi: 10.1042/bj2130289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Neame P. J., Choi H. U., Rosenberg L. C. The isolation and primary structure of a 22-kDa extracellular matrix protein from bovine skin. J Biol Chem. 1989 Apr 5;264(10):5474–5479. [PubMed] [Google Scholar]
  18. Okamoto O., Suzuki Y., Kimura S., Shinkai H. Extracellular matrix 22-kDa protein interacts with decorin core protein and is expressed in cutaneous fibrosis. J Biochem. 1996 Jan;119(1):106–114. doi: 10.1093/oxfordjournals.jbchem.a021194. [DOI] [PubMed] [Google Scholar]
  19. Pintavorn P., Ballermann B. J. TGF-beta and the endothelium during immune injury. Kidney Int. 1997 May;51(5):1401–1412. doi: 10.1038/ki.1997.192. [DOI] [PubMed] [Google Scholar]
  20. Santra M., Skorski T., Calabretta B., Lattime E. C., Iozzo R. V. De novo decorin gene expression suppresses the malignant phenotype in human colon cancer cells. Proc Natl Acad Sci U S A. 1995 Jul 18;92(15):7016–7020. doi: 10.1073/pnas.92.15.7016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Sato Y., Okada F., Abe M., Seguchi T., Kuwano M., Sato S., Furuya A., Hanai N., Tamaoki T. The mechanism for the activation of latent TGF-beta during co-culture of endothelial cells and smooth muscle cells: cell-type specific targeting of latent TGF-beta to smooth muscle cells. J Cell Biol. 1993 Dec;123(5):1249–1254. doi: 10.1083/jcb.123.5.1249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Sato Y., Rifkin D. B. Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture. J Cell Biol. 1989 Jul;109(1):309–315. doi: 10.1083/jcb.109.1.309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Sato Y., Tsuboi R., Lyons R., Moses H., Rifkin D. B. Characterization of the activation of latent TGF-beta by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self-regulating system. J Cell Biol. 1990 Aug;111(2):757–763. doi: 10.1083/jcb.111.2.757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Sporn M. B., Roberts A. B. Transforming growth factor-beta: recent progress and new challenges. J Cell Biol. 1992 Dec;119(5):1017–1021. doi: 10.1083/jcb.119.5.1017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Superti-Furga A., Rocchi M., Schäfer B. W., Gitzelmann R. Complementary DNA sequence and chromosomal mapping of a human proteoglycan-binding cell-adhesion protein (dermatopontin). Genomics. 1993 Aug;17(2):463–467. doi: 10.1006/geno.1993.1348. [DOI] [PubMed] [Google Scholar]
  26. Svensson L., Heinegård D., Oldberg A. Decorin-binding sites for collagen type I are mainly located in leucine-rich repeats 4-5. J Biol Chem. 1995 Sep 1;270(35):20712–20716. doi: 10.1074/jbc.270.35.20712. [DOI] [PubMed] [Google Scholar]
  27. Takeuchi Y., Kodama Y., Matsumoto T. Bone matrix decorin binds transforming growth factor-beta and enhances its bioactivity. J Biol Chem. 1994 Dec 23;269(51):32634–32638. [PubMed] [Google Scholar]
  28. Vogel K. G., Paulsson M., Heinegård D. Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. Biochem J. 1984 Nov 1;223(3):587–597. doi: 10.1042/bj2230587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Vogel K. G., Trotter J. A. The effect of proteoglycans on the morphology of collagen fibrils formed in vitro. Coll Relat Res. 1987 Jun;7(2):105–114. doi: 10.1016/s0174-173x(87)80002-x. [DOI] [PubMed] [Google Scholar]
  30. Yamaguchi Y., Mann D. M., Ruoslahti E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature. 1990 Jul 19;346(6281):281–284. doi: 10.1038/346281a0. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES